Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOX-GC adjuvant chemotherapy feasibility in stage III gastric cancer
jRCTs041180052Completed
- Start
- Jul 2016
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tegafur and oxaliplatin in gastric cancer (GC). Primary endpoint: Treatment completion rate of protocol treatment (5 courses). Started Jul 2016; status: completed.
02
Drugs
tegafuroxaliplatin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on jRCTs041180052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180052.